Pharma-Bio Serv, Inc.
PBSV · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $4 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$4 | $0 | $0 | $0 |
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | 81,118.3% | -2.2% | 5.9% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 29.3% | 33.9% | 31.1% | 31.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0% | -1.6% | -1.7% | -4.6% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -0% | 3.9% | 0.3% | 0.7% |
| EPS Diluted | -0.009 | 0.004 | 0.37 | 0.035 |
| % Growth | -311.9% | -98.9% | 972.5% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |